Cited by 33Amyotrophic Lateral Sclerosis ResearchSmoking Behavior and CessationMultiple Sclerosis Research Studies

Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR

Open access
Peters, Susan, Visser, Anne E, D'Ovidio, Fabrizio, Vlaanderen, Jelle, Portengen, Lützen, Beghi, Ettore, Chio, Adriano, Logroscino, Giancarlo +5 more·2020·Journal of Neurology, Neurosurgery & Psychiatry

Abstract

Background: We investigated the association between cigarette smoking and risk of amyotrophic lateral sclerosis (ALS) in a pooled analysis of population-based case–control studies and explored the independent effects of intensity, duration and time-since-quitting. Methods: ALS cases and controls, matched by age, sex and region, were recruited in the Netherlands, Italy and Ireland (*Euro-MOTOR project). Demographics and detailed lifetime smoking histories were collected through questionnaires. Effects of smoking status, intensity (cigarettes/day), duration (years), pack-years and time-since-quitting (years) on ALS risk were estimated using logistic regression models, adjusting for age, sex, alcohol, education and centre. We further investigated effect modification of the linear effects of pack-years by intensity, duration and time-since-quitting using excess OR (eOR) models. Results: Analyses were performed on 1410 cases and 2616 controls. Pack-years were positively associated with ALS risk; OR=1.26 (95% CI: 1.03 to 1.54) for the highest quartile compared with never smokers. This association appeared to be predominantly driven by smoking duration (p trend=0.001) rather than intensity (p trend=0.86), although the trend for duration disappeared after adjustment for time-since-quitting. Time-since-quitting was inversely related to ALS (p trend<0.0001). The eOR decreased with time-since-quitting smoking, until about 10 years prior to disease onset. High intensity smoking with shorter duration appeared more deleterious than lower intensity for a longer duration. Conclusions: Our findings provide further support for the association between smoking and ALS. Pack-years alone may be insufficient to capture effects of different smoking patterns. Time-since-quitting appeared to be an important factor, suggesting that smoking may be an early disease trigger.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jnnp-2019-320986

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some associations between environmental risk factors and ALS potentially vary by age, sex, and genetic factors.

    “with some of the associations potentially varying by age, sex, and genetic factors [11–15].”

    From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [15]

    The Introduction says environmental exposures may act on genetic predisposition, and the Neurodegeneration discussion reports a somewhat stronger smoking association after excluding cases with a C9orf72 repeat expansion. The Methods say age and sex were adjustment variables, but our copy does not report that the smoking–ALS association varies by either age or sex. No page numbers are available in the indexed passages. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Some observational studies showed a positive association for current smoking but no association for former smoking with ALS risk.

    “Some observational studies showed a positive association for current smoking but no association for former smoking [7, 14, 15], while Mendelian Randomization studies have provided evidence for a causal link between smoking and risk for ALS [49].”

    From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [15]

    The Neurodegeneration section reports a positive association for current smoking (OR 1.47, 95% CI 1.20–1.79). The Results give counts for former smokers, and the Discussion reports declining ALS risk with time since quitting, but the available passages do not establish that former smoking had no association with ALS risk compared with never smoking. No page numbers are provided in our copy. (LLM, conf=0.79)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 22

  1. al-chalabi a, hardiman O. The epidemiology of aLs: a conspiracy of genes, environment and time. Nat Rev Neurol 2013;9:617-28. · DOI
  2. armon c. smoking may be considered an established risk factor for sporadic aLs. Neurology 2009;73:1693-8. · DOI
  3. alonso a, Logroscino G, hernán Ma. smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry 2010;81:1249-52. · DOI · Paper page
  4. de Jong sW, huisman MhB, sutedja Na, et al. smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study. Am J Epidemiol 2012;176:233-9. · DOI
  5. Gallo V, Bueno-De-Mesquita hB, Vermeulen R, et al. smoking and risk for amyotrophic lateral sclerosis: analysis of the epIc cohort. Ann Neurol 2009;65:378-85. · DOI
  6. Wang h, O'Reilly ÉJ, Weisskopf MG, et al. smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol 2011;68:13. doi:10.1001/archneurol.2010.367. [epub ahead of print]. · DOI
  7. Lubin Jh, caporaso Ne. cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev 2006;15:517-23. · DOI
  8. Vlaanderen J, portengen L, schüz J, et al. effect modification of the association of cumulative exposure and cancer risk by intensity of exposure and time since exposure cessation: a flexible method applied to cigarette smoking and lung cancer in the synergy study. Am J Epidemiol 2014;179:290-8. · DOI
  9. van der Mark M, Nijssen pcG, Vlaanderen J, et al. a case-control study of the protective effect of alcohol, coffee, and cigarette consumption on parkinson disease risk: time-since-cessation modifies the effect of tobacco smoking. PLoS One 2014;9:e95297. · DOI
  10. Lee W-c. excess relative risk as an effect measure in case-control studies of rare diseases. PLoS One 2014;10:e0121141. · DOI
  11. Brooks BR, Miller RG, swash M, et al. el escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9. · DOI · Paper page
  12. D'Ovidio F, Rooney JpK, Visser ae, et al. critical issues in aLs case-control studies: the case of the euro-MOTOR study. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:411-8. · DOI
  13. pearce N. analysis of matched case-control studies. BMJ 2016;352. Strasbourg. Protected by copyright. on October 25, 2019 at Universite Louis Pasteur http://jnnp.bmj.com/ J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2019-320986 on 21 August 2019. Downloaded from · DOI
  14. DeJesus-hernandez M, Mackenzie IR, Boeve BF, et al. expanded GGGGcc hexanucleotide repeat in noncoding region of c9orf72 causes chromosome 9p-linked FTD and aLs. Neuron 2011;72:245-56. · DOI · Paper page
  15. Visser ae, Rooney JpK, D'Ovidio F, et al. Multicentre, cross-cultural, population- based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2018;89:797-803. · DOI
  16. Richardson DB. a simple approach for fitting linear relative rate models in sas. Am J Epidemiol 2008;168:1333-8. · DOI
  17. Thomas Dc. Invited commentary: is it time to retire the "pack-years" variable? Maybe not! Am J Epidemiol 2014;179:299-302. · DOI
  18. al-chalabi a, calvo a, chio a, et al. analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol 2014;13:1108-13. · DOI
  19. swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 2014;10:661-70. · DOI
  20. Fry Js, Lee pN, Forey Ba, et al. how rapidly does the excess risk of lung cancer decline following quitting smoking? a quantitative review using the negative exponential model. Regul Toxicol Pharmacol 2013;67:13-26. · DOI
  21. O'Reilly ÉJ, Wang M, adami h-O, et al. prediagnostic body size and risk of amyotrophic lateral sclerosis death in 10 studies. Amyotroph Lateral Scler Frontotemporal Degener 2018;19:406. doi:10.1080/21678421.2018.1452944. [epub ahead of print]. · DOI
  22. chadeau-hyam M, Tubert-Bitter p, Guihenneuc-Jouyaux c, et al. Dynamics of the risk of smoking-induced lung cancer: a compartmental hidden Markov model for longitudinal analysis. Epidemiology 2014;25:28-34. · DOI

Cited by

Sorted by citations

Authors
Peters, S., Visser, A. E., D'Ovidio, F., Vlaanderen, J., Portengen, L., Beghi, E., Chio, A., Logroscino, G., Hardiman, O., Pupillo, E., Veldink, J. H., Vermeulen, R., & van den Berg, L. H.
Affiliations
  • Utrecht University (NL)
  • University Medical Center Utrecht (NL)
  • Mario Negri Institute for Pharmacological Research (IT)
  • University of Bari Aldo Moro (IT)
  • Trinity College Dublin (IE)
Corresponding author
Peters, Susan
Venue
Journal of Neurology, Neurosurgery & Psychiatry
Publisher
BMJ
Published
2019-08-21
Volume
91
Issue
1
Pages
33-39
ISSN
  • 0022-3050 (ISSN-L)
  • 1468-330X
OpenAlex
W2969980778
Cited by
33
References
1
Citations by year
2026: 3 · 2024: 9 · 2023: 3 · 2022: 4 · 2021: 8 · 2020: 6
FWCI
3.04
Type
journal article
Language
en
Open access
Locations
  • Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
Funders
  • Netherlands ALS Foundation
  • European Community's Health Seventh Framework Programme (FP7/2007-2013, grant number 259867)
  • Netherlands Organization for Health Research and Development (Vici Scheme, JPND (STRENGTH))
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
Keywords
cigarette smoking, amyotrophic lateral sclerosis, pack-years, smoking intensity, smoking duration, time since quitting, effect modification, smoking cessation, neurodegenerative disease risk
MeSH terms
Cigarette Smoking, Adult, Aged, Amyotrophic Lateral Sclerosis, Female, Humans, Ireland, Italy, Male, Middle Aged, Netherlands, Risk Factors, Smoking, Socioeconomic Factors, Case-Control Studies, Smoking Cessation, Risk Assessment, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review